# Cue Biopharma (CUE) — Analyst Forecast

CUE · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/cue/forecast

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Sep 18, 2026 | B. Riley Securities | Initiated Coverage | Buy | $83.00 |
| Aug 25, 2025 | LUCID CAPITAL MARKETS | Initiated Coverage | Buy | $4.00 |
| Apr 2, 2025 | Citizens Capital Markets | Maintained | Market Outperform | $2.00 |
| Aug 20, 2024 | Stifel | Maintained | Buy | $4.00 |
| Jul 26, 2024 | Piper Sandler | Maintained | Overweight | $3.00 |
| Jul 26, 2024 | JMP Securities | Maintained | Market Outperform | $2.00 |
| Apr 9, 2024 | Oppenheimer | Maintained | Outperform | $10.00 |
| Apr 9, 2024 | Stifel | Maintained | Buy | $8.00 |
| Apr 3, 2024 | Piper Sandler | Maintained | Overweight | $8.00 |
| Mar 13, 2024 | Jefferies | Initiated Coverage | Buy | $6.00 |
| Nov 6, 2023 | Piper Sandler | Maintained | Overweight | $8.00 |
| Jun 15, 2023 | Stifel | Maintained | Buy | $8.00 |
| May 15, 2023 | JMP Securities | Maintained | Outperform | $15.00 |

## Frequently Asked Questions

### What is the latest analyst rating on CUE?

On Sep 18, 2026, B. Riley Securities initiated coverage of Cue Biopharma at Buy with a price target of $83.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).